Monday, November 12, 2018




In the fields of medicine, biotechnology, and pharmacology, drug discovery is the process by which new candidate medications are discovered. ... Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials.#clinicalpharmacycongress_2019 #april_22_23  #tokyo #japan

Saturday, November 3, 2018


#Pharmacist-Only #medicines (also known as Restricted #medicines) is a relatively small group of #medicines that can be purchased from a #pharmacist without a #doctor's prescription. They are not available for self-selection from the pharmacy shelves, and the sale must be made by a #pharmacist.

Friday, November 2, 2018

The . The plan is a complex document that entails the entire strategy of a , describing the that will be carried out for a entity, created by a .

Wednesday, October 31, 2018

To explore professionals' perceptions related to the quality of the Clinical pharmacy services quality improvement Interprofessional relations work satisfaction services provider.

Saturday, October 27, 2018

In medicine, #biotechnology, and #pharmacology, #drug discovery is the process by which drugs are discovered and/or designed. In the past, most #drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. #clinical pharmacy congress 2019 #08-09 April  #tokyo_japan

Monday, October 15, 2018

industrial pharmacy

Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others.

Tuesday, October 9, 2018

#Regulatory Affairs (RA), also called #Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. #Regulatory Affairs also has a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, #Biologic and #functional foods). Most companies, whether they are major multinational pharmaceutical corporations or small, #innovative biotechnology companies, have specialist departments of Regulatory Affairs professionals. The success of regulatory strategy is less dependent on the regulations than on how they are interpreted, applied, and communicated within companies and to outside constituents.#clinicalpharmacy ,
#japan ,#April 08-09,2019